The challenge of stroke prevention with intracranial arterial stenosis
Tanya N Turan1, Alison Smock, Marc I Chimowitz
1MUSC Stroke Program, Suite 501, Harborview Office Tower, 19 Hagood Ave, Charleston, SC, 29425, USA, turan@musc.edu.
Insights
Secondary prevention for symptomatic intracranial atherosclerotic disease is challenging. Aggressive risk factor management is the current standard, while endovascular and surgical options require further study.
Area of Science:
- Neurology
- Vascular Medicine
- Cardiovascular Research
Background:
- Symptomatic intracranial atherosclerotic disease (ICAD) carries a high risk of recurrent stroke.
- Secondary stroke prevention in ICAD patients presents significant clinical challenges.
- Current treatment paradigms focus on managing vascular risk factors.
Purpose of the Study:
- To review the current strategies for secondary prevention in patients with symptomatic ICAD.
- To evaluate the established and emerging therapeutic options for ICAD.
- To emphasize the importance of risk factor modification in managing ICAD.
Main Methods:
- Literature review of studies on intracranial atherosclerotic disease.
- Analysis of data regarding medical, endovascular, and surgical interventions.
- Assessment of the safety and efficacy of aggressive vascular risk factor management.
Main Results:
- Aggressive medical management of vascular risk factors is proven safe and effective for most high-risk ICAD patients.
- The definitive roles of endovascular and surgical therapies in ICAD secondary prevention remain uncertain.
- Risk factor control is the cornerstone of evidence-based treatment for ICAD.
Conclusions:
- Aggressive risk factor control is the current mainstay of evidence-based treatment for symptomatic intracranial atherosclerotic disease.
- Further research is needed to clarify the role of endovascular and surgical interventions.
- Future studies may uncover novel therapeutic strategies for ICAD management.
Abstract:
Patients with symptomatic intracranial atherosclerotic disease have a high risk of recurrent stroke, and secondary prevention in these patients remains a challenge. Aggressive medical management of vascular risk factors is safe and effective for most high risk patients, but the role of endovascular and surgical therapies still remain uncertain. Future studies may identify novel therapeutic strategies for patients with intracranial atherosclerotic disease, but aggressive risk factor control remains the mainstay of evidenced-based treatment at this time.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Atherosclerosis IV: Nursing Management
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Hemorrhagic Stroke l: Introduction


